MSB 5.50% $1.38 mesoblast limited

Ann: Mesoblast Technology Shows Potential In Type 1 Diabetes, page-6

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 349 Posts.
    lightbulb Created with Sketch. 7
    Well going on how quickly the FDA move could be 10 years.The Japanese are leaders in this space and will be approving stem cell treatments after successful completion of phase 2 trials.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.